0001213900-22-013589.txt : 20220318
0001213900-22-013589.hdr.sgml : 20220318
20220318161544
ACCESSION NUMBER: 0001213900-22-013589
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220316
FILED AS OF DATE: 20220318
DATE AS OF CHANGE: 20220318
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sarnoff David
CENTRAL INDEX KEY: 0001751105
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38803
FILM NUMBER: 22752721
MAIL ADDRESS:
STREET 1: 1 ROCKEFELLER PLAZA, SUITE 1039
CITY: NEW YORK
STATE: NY
ZIP: 10020
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Hoth Therapeutics, Inc.
CENTRAL INDEX KEY: 0001711786
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 821553794
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 ROCKEFELLER PLAZA, SUITE 1039
CITY: NEW YORK
STATE: NY
ZIP: 10020
BUSINESS PHONE: 551-578-2261
MAIL ADDRESS:
STREET 1: 1 ROCKEFELLER PLAZA, SUITE 1039
CITY: NEW YORK
STATE: NY
ZIP: 10020
4
1
ownership.xml
X0306
4
2022-03-16
0
0001711786
Hoth Therapeutics, Inc.
HOTH
0001751105
Sarnoff David
C/O HOTH THERAPEUTICS, INC.
1 ROCKEFELLER PLAZA, SUITE 1039
NEW YORK
NY
10020
1
0
0
0
Options
0.591
2022-03-16
4
A
0
40000
0
A
2022-03-16
2032-03-16
Common Stock
40000
40000
D
The options were issued pursuant to the Issuer's 2018 Equity Incentive Plan and vested in full upon grant.
/s/ Jane H. Springer as Attorney-In-Fact for David Sarnoff
2022-03-18